Showing 1 - 7 results of 7 for search 'Carlo Milandri', query time: 0.03s Refine Results
  1. 1
    Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. <i>J. Pers. Med.</i> 2022, <i>12</i>, 555

    Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative... by Maria Antonietta Mazzei, Giulio Bagnacci, Armando Perrella, Nunzia Di Meglio, Stefania Angela Piccioni, Francesco Bloise, Daniele Marrelli, Carlo Milandri, Gianni Mura

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients

    Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients by Giammaria Fiorentini MD, Donatella Sarti PhD, Virginia Casadei MD, Carlo Milandri MD, Patrizia Dentico MD, Andrea Mambrini MD, Roberto Nani MD, Caterina Fiorentini MD, Stefano Guadagni MD

    Published 2019-09-01
    Get full text
    Article
  3. 3
    Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study

    Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study by Giammaria Fiorentini MD, Donatella Sarti PhD, Carlo Milandri MD, Patrizia Dentico MD, Andrea Mambrini MD, Caterina Fiorentini MD, Gianmaria Mattioli MD, Virginia Casadei MD, Stefano Guadagni MD

    Published 2019-02-01
    Get full text
    Article
  4. 4
    Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial

    Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial by Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori, Oriana Nanni

    Published 2020-07-01
    Get full text
    Article
  5. 5
    Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer

    Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer by Maria Bencivenga, Silvia Ministrini, Paolo Morgagni, Gianni Mura, Daniele Marrelli, Carlo Milandri, Maria Antonietta Mazzei, Mattia Berselli, Manlio Monti, Luigina Graziosi, Rossella Reddavid, Fausto Rosa, Leonardo Solaini, Annibale Donini, Uberto Fumagalli Romario, Franco Roviello, Giovanni de Manzoni, Guido Alberto Massimo Tiberio

    Published 2023-12-01
    Get full text
    Article
  6. 6
    Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial

    Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial by Manlio Monti, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, Silvia Bozzarelli, Annibale Donini, Luigina Graziosi, Verena De Angelis, Giovanni De Manzoni, Maria Bencivenga, Valentina Mengardo, Emilio Parma, Carlo Milandri, Gianni Mura, Alessandra Signorini, Gianluca Baiocchi, Sarah Molfino, Giovanni Sgroi, Francesca Steccanella, Stefano Rausei, Ilaria Proserpio, Jacopo Viganò, Silvia Brugnatelli, Andrea Rinnovati, Stefano Santi, Giorgio Ercolani, Flavia Foca, Linda Valmorri, Dino Amadori, Giovanni Luca Frassineti

    Published 2020-09-01
    Get full text
    Article
  7. 7
    Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial

    Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial by Jennifer M.T.A. Meessen, Daniela Cardinale, Fabio Ciceri, Maria Teresa Sandri, Maurizio Civelli, Barbara Bottazzi, GianFranco Cucchi, Elisabetta Menatti, Maurizio Mangiavacchi, Gianluigi Condorelli, Enrico Barbieri, Stefania Gori, Alessandro Colombo, Giuseppe Curigliano, Michela Salvatici, Paolo Pastori, Francesco Ghisoni, Alessandra Bianchi, Cristina Falci, Pietro Cortesi, Alberto Farolfi, Anna Monopoli, Carlo Milandri, Marco Bregni, Alessandra Malossi, Daniele Nassiacos, Claudio Verusio, Lidia Staszewsky, Roberto Leone, Deborah Novelli, Giovanna Balconi, Enrico B. Nicolis, Maria Grazia Franzosi, Serge Masson, Cecilia Garlanda, Alberto Mantovani, Carlo M. Cipolla, Roberto Latini, ICOS‐ONE Study Investigators

    Published 2020-08-01
    Get full text
    Article

Search Tools: